Cellectis SA belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Cellectis SA (CLLS) current stock price?
As of the latest data, Cellectis SA stock price is $3.73, with a previous close of $3.49. Cellectis SA gained $0.24 in the last trading session, representing a 6.88% increase.
What is Cellectis SA (CLLS) current market capitalization?
Cellectis SA market cap is approximately 269.77 million.
What is Cellectis SA (CLLS) Earnings Per Share (EPS)?
The trailing EPS is -$0.33, and the forward EPS is -$0.62.
What is Cellectis SA (CLLS) EBITDA?
Cellectis SA EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 7.71 million.
Does Cellectis SA (CLLS) pay dividends?
No. Cellectis SA does not pay a dividend.
How did Cellectis SA (CLLS) perform in its most recent earnings report?
In the last report (September 30, 2025), Cellectis SA posted an EPS surprise of 104.28% and a revenue surprise of 329.7%.
When is Cellectis SA (CLLS) next earnings report?
Cellectis SA is expected to release its next earnings report on December 31, 2025.
What is Cellectis SA (CLLS) beta (volatility) score?
Cellectis SA has a beta of 2.977, indicating very high volatility compared to the market.